TickerFactsScreenerDevelopers

Altimmune, Inc. (ALT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$14.86M2011: -$7.81M2012: -$2.32M2017: -$20.21M2018: -$9.39M2019: -$9.60M2020: -$34.31M2021: -$78.24M2022: -$62.59M2023: -$75.81M2024: -$79.85M2025: -$67.53M-$67.53M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$67.53M+15.4%
2024-$79.85M-5.3%
2023-$75.81M-21.1%
2022-$62.59M+20.0%
2021-$78.24M-128.1%
2020-$34.31M-257.3%
2019-$9.60M-2.3%
2018-$9.39M+53.6%
2017-$20.21M—
2012-$2.32M+70.3%
2011-$7.81M+47.5%
2010-$14.86M—